APCO Upgrades Mylife100A with New Formula, Targets Longevity Market

HL is pressing ahead with full force to expand its customer base in the second half of 2026 by opening a new iCare branch at Phutthamonthon Sai 4, while accelerating the development of innovative products under the Prime brand, a line of health-care supplements including Prime Immuliv, Prime G3 and an absorption-enhancing product, as well as skin-care products and herbal products under the Q brand that have won international awards. The company is also moving into the Pet Health market in line with the pet humanization trend by sourcing and distributing supplements, vitamins and medicines for pets. Meanwhile, PTG has received the Human Rights Awards 2026 at the outstanding level in the large business organisation category for the second consecutive year. TMAN, for its part, has opened the Heaven Herb factory in Pathum Thani province, showcasing the potential of a production base driven by modern technology, with a target of creating 15 new products within five years to meet global demand and the growing longevity trend, while continuing to transform the factory with an investment budget of 50 million baht per year to help drive Thailand toward becoming a Global Wellness Hub.

T. Man Pharmaceutical Public Company Limited, or TMAN, has set a target of reaching 4 billion baht in total company revenue in 2030, along with a growth target of no less than 10-15% per year, above the industry's average growth rate of about 6-7% per year. Chief Executive Officer Praphon Thanachotiphan disclosed this at the event "TMAN opens Heaven Herb factory, driving Thailand toward a Wellness & Longevity Hub," saying the company is pushing into the over-the-counter and pharmacy market, targeting a top-10 market share from its current ranking of around 15th, and driving products into provincial hospitals, regional hospitals, medical schools, and private hospitals to move up to a top-10 market share in that group from its current ranking in the low 20s. In overseas markets, the company plans to push its main brand, Propolis, to become a regional brand, and will expand into 2-3 more overseas markets this year from the previous 7 countries, reaching nearly 10 countries within this year. It recently signed contracts with partners in South Korea and Indonesia, with revenue expected to begin being recognized in late 2026 or early 2027, and is in the process of penetrating the Philippines and Middle Eastern markets such as Oman. The company also aims to launch 15-20 new products per year, having already launched about 7-8 this year, which have consistently generated double-digit growth. For its anti-aging supplement product group, it targets a 5% share of total revenue within the next 3-5 years, and recently partnered with the mother-and-baby brand Lamoon to expand its consumer base into the mother-and-baby segment, with plans to bring in its research and development team to develop products to create a new S-Curve and build Longevity into a new growth engine. Within 5 years it will deliver approximately 15 products in the Science-backed Longevity Solutions group, and it targets revenue from that group at 5-10% of the portfolio in the next 3-5 years. It estimates Thailand's healthcare market value in 2026 at approximately 37.65 billion US dollars, expected to rise to approximately 61.38 billion US dollars in 2032, growing at an average of 8.49% per year.

Thai Union Ingredient (TUI) has launched its Longevity portfolio at Vitafoods Asia 2026, presenting innovative ingredient solutions derived from tuna. The portfolio includes DHA fish oil, collagen, and bio-calcium, all backed by a 100% traceability system across the entire supply chain. These three ingredients are developed from by-products of tuna processing, namely fish heads, skin, and bones, at facilities in Germany, Samut Sakhon, and Songkhla. The company aims to generate at least $30 million in revenue from ThalaCol™ within five years and to increase premium-grade omega-3 oil sales with a compound annual growth rate of over 50% by 2030.